Ventures in Residence

Vaxess Technologies

Vaxess was founded in 2012 to enable next generation vaccines. The company has combined VC funding with grants and partnerships to advance two platforms. Matrix is a formulation and drying system that reduces the need for cold storage of vaccines and diagnostics. Mimix is a sustained-release patch for delivery of vaccines and therapeutics, offering simplified administration and enhanced efficacy.

Website
http://www.vaxess.com

Schools
  • Harvard Business School
  • Harvard Kennedy School
  • Harvard Law School
  • Harvard School of Engineering and Applied Sciences
Semesters
  • Fall 2016
Venture Status
  • Alumni
Industry
  • Biologics/Therapeutics
  • Devices/Hardware
  • Global/Public Health
  • Life/Physical Sciences

Team News

Designing a More Efficient, Temperature-Proof Vaccine

Vaccines Without Needles? Yes, Please!